Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 100,526 | 126,224 | 62,535 | 100,041 | 94,672 |
| Depreciation Amortization | 23,007 | 16,843 | 16,110 | 13,482 | 9,978 |
| Income taxes - deferred | -3,635 | 699 | 19,306 | -3,700 | -2,572 |
| Accounts payable and accrued liabilities | 1,835 | -1,720 | 3,043 | -1,341 | 2,481 |
| Other Working Capital | -8,790 | -7,749 | 7,589 | 10,410 | 10,328 |
| Other Operating Activity | 13,790 | 17,822 | 15,191 | 17,999 | -3,421 |
| Operating Cash Flow | $126,733 | $152,119 | $123,774 | $136,891 | $111,466 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,552 | -11,052 | -13,198 | -32,687 | -23,544 |
| Net Acquisitions | N/A | N/A | N/A | -7 | -1,580 |
| Purchase Of Investment | N/A | -86,396 | N/A | N/A | N/A |
| Sale Of Investment | 63,539 | 22,857 | N/A | N/A | N/A |
| Other Investing Activity | 507 | 5,588 | 296 | 811 | 0 |
| Investing Cash Flow | $47,494 | $-69,003 | $-12,902 | $-31,883 | $-25,124 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,000 | N/A | 3,500 | 73,700 | N/A |
| Common Stock Repurchased | -150,000 | -105,375 | -50,000 | -64,610 | -61,181 |
| Other Financing Activity | -7,052 | 98 | -3,816 | -73,950 | 12,024 |
| Financing Cash Flow | $-152,052 | $-105,277 | $-50,316 | $-64,860 | $-49,157 |
| Exchange Rate Effect | -1,721 | -11,140 | 11,027 | -7,929 | -5,101 |
| Beginning Cash Position | 217,234 | 250,535 | 178,952 | 146,733 | 111,126 |
| End Cash Position | 237,688 | 217,234 | 250,535 | 178,952 | 143,210 |
| Net Cash Flow | $20,454 | $-33,301 | $71,583 | $32,219 | $32,084 |
| Free Cash Flow | |||||
| Operating Cash Flow | 126,733 | 152,119 | 123,774 | 136,891 | 111,466 |
| Capital Expenditure | -16,569 | -11,433 | -13,220 | -32,698 | -23,729 |
| Free Cash Flow | 110,164 | 140,686 | 110,554 | 104,193 | 87,737 |